BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 922119)

  • 1. Plasma cell acid phosphatase, a discriminative test for benign and malignant monoclonal gammopathies.
    Cassuto JP; Hammou JC; Pastorelli E; Dujardin P; Masseyeff R
    Biomedicine; 1977 Jul; 27(5):197-9. PubMed ID: 922119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Usefulness of plasma cell acid phosphatase in the differential diagnosis of monoclonal gammopathies].
    Santus G; Pirali F; Inzoli MR
    Minerva Med; 1981 Sep; 72(37):2479-83. PubMed ID: 7279268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Plasma cell acid phosphatase in the differential diagnosis of monoclonal gammopathies].
    Milanesi B; Tafuri C; Perini M; Rota G; Peretti P
    Quad Sclavo Diagn; 1984 Jun; 20(2):149-54. PubMed ID: 6528014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cytological study of acid phosphatase activity of plasma cells in monoclonal gammopathies].
    Ricci C; Coscia GG; Bellone G; Novarini M; Discalzi GL; Cascio G
    Acta Med Austriaca; 1984; 11(2):37-43. PubMed ID: 6741437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Biological and clinical significance of plasma-cell acid phosphatase in multiple myeloma].
    Musto P; Barbieri D; Gennari M; Spanedda R; Scapoli G; Carotenuto M; Castoldi G
    Recenti Prog Med; 1986 Oct; 77(10):452-60. PubMed ID: 3823590
    [No Abstract]   [Full Text] [Related]  

  • 6. [Plasma cell beta-glucuronidase and monoclonal gammapathies (author's transl)].
    Seigneurin D; David J; Sotto JJ; Hollard D
    Pathol Biol (Paris); 1979 Oct; 27(8):467-71. PubMed ID: 392416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cytochemistry in the differential diagnosis of patients with a monoclonal component].
    Portero JA; Martín S
    Sangre (Barc); 1984; 29(5):907-12. PubMed ID: 6441293
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cytochemical studies of bone marrow plasma cells in monoclonal gammapathies (author's transl)].
    Miliani A; Anichini P; di Guglielmo R; Pellegrini G; Firorelli C; Cuccuini A; Cozzolino F; Vercelli D
    Nouv Rev Fr Hematol (1978); 1982; 24(1):27-33. PubMed ID: 6461844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of the usefulness of various cytoenzymatic studies in the differential diagnosis of multiple myeloma and plasmacytic reaction of bone marrow].
    Mariańska B; Maj S; Apel D; Płachecka M
    Acta Haematol Pol; 1985; 16(3-4):117-21. PubMed ID: 3835767
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasma cell acid phosphatase as an adjunct in the differential diagnosis of monoclonal immunoglobulinemias.
    Tortarolo M; Cantore N; Grande M; Buonanno G; Dammacco F
    Acta Haematol; 1981; 65(2):103-7. PubMed ID: 6785954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of bone marrow plasma cell kinetics in the differential diagnosis of monoclonal gammopathies].
    Pini E; Tassinari D; Gianni L; Fattori P; Sartori S; Pasquini E; Ravaioli A
    Recenti Prog Med; 1995 Jun; 86(6):242. PubMed ID: 7624585
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparative cytochemical study of some enzymatic activities in normal and myelomatous plasma cells (author's transl)].
    Invernizzi R; Ippoliti G; Cattaneo G; Trpin L; Casirola G; Carnevale-Maffé G; Cordani M
    Haematologica; 1979 Dec; 64(6):726-34. PubMed ID: 161879
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunophenotypic aberrations, DNA content, and cell cycle analysis of plasma cells in patients with myeloma and monoclonal gammopathies.
    Lima M; Teixeira Mdos A; Fonseca S; Gonçalves C; Guerra M; Queirós ML; Santos AH; Coutinho A; Pinho L; Marques L; Cunha M; Ribeiro P; Xavier L; Vieira H; Pinto P; Justiça B
    Blood Cells Mol Dis; 2000 Dec; 26(6):634-45. PubMed ID: 11358356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neural cell adhesion molecule expression in plasma cells in bone marrow biopsies and aspirates allows discrimination between multiple myeloma, monoclonal gammopathy of uncertain significance and polyclonal plasmacytosis.
    Martín P; Santón A; Bellas C
    Histopathology; 2004 Apr; 44(4):375-80. PubMed ID: 15049904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cytochemistry of plasma cells (author's transl)].
    Miliani A; Anichini P; Pellegrini G; Firorelli C; Cozzolino F
    Haematologica; 1979 Oct; 64 Suppl():35-9. PubMed ID: 161540
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasma cell acid phosphatase score in multiple myeloma and related disorders.
    Hoffmann JJ; Breed WP; Swaak-Lammers N
    Br J Haematol; 1985 Jan; 59(1):67-72. PubMed ID: 3970852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Benign and malignant plasma cell dyscrasias: methods of study].
    Geniram A; Fiorini G; Spotti D; Frezzini G; Guarino P; Venturino M; Marini U
    Haematologica; 1984; 69(2):163-77. PubMed ID: 6203816
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and multiple myeloma.
    Ocqueteau M; Orfao A; Almeida J; Bladé J; González M; García-Sanz R; López-Berges C; Moro MJ; Hernández J; Escribano L; Caballero D; Rozman M; San Miguel JF
    Am J Pathol; 1998 Jun; 152(6):1655-65. PubMed ID: 9626070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Monoclonal gammopathies. Progress in differential diagnosis based on immunologic markers].
    Caballero MD; González M; San Miguel J
    Sangre (Barc); 1984; 29(5):913-7. PubMed ID: 6441294
    [No Abstract]   [Full Text] [Related]  

  • 20. [Importance of selected laboratory indicators in the differential diagnosis and monitoring of multiple myeloma].
    Maisnar V; Tousková M; Malý J; Krejsek J; Kmonícek M; Kopecký O
    Vnitr Lek; 2002 Apr; 48(4):290-7. PubMed ID: 12061177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.